Table of Contents
Kalorama Information's Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.
There is an expanding market for human blood and blood components as a result of the growing and aging populations, particularly in the developed nations. While some countries such as India and the Philippines set prices for blood and blood components, in many of the developed nations including the U.S., there is no uniform, fixed price for blood. Rather, the cost varies from country to country and region to region, with even nearby centers often charging different prices and fluctuations often occurring.
Blood products covered in the report include:
Red Blood Cells (RBCs)
Other Plasma Products
Synthetic HBOC and PFC Agents
Although the blood supplies in the developed nations are, to a very high degree, free of disease-causing viruses, the risk of transfusion-related infection is nonetheless present. Because these supplies contain human blood, achieving 100% virus eradication is unlikely. A variety of infectious agents can be present in blood, including viruses (e.g., HIV-1, hepatitis B and C, HTLV, West Nile virus), bacteria, protozoans, Chagas disease, Lyme Disease and prions (e.g., the agent of variant Crueutzfeldt-Jakob disease, which is the human form of mad cow disease). Nonetheless, blood safety is relatively high, due to the widespread usage of blood testing. As of 2014, the main residual risk is due to hepatitis B virus - ranging from 10 in Spain to 1.6 per million donations in France and Germany.
Testing markets covered include:
Blood Banking and Plasmapheresis Testing
Human Immunodeficiency Virus (HIV) Testing
Hepatitis A Virus Testing
Hepatitis B Virus Testing
Hepatitis C Virus Testing
Human T-Cell Leukemia Virus Testing
West Nile Virus Testing
Other Safety Testing
High-blood-loss procedure estimates
Products on the market and in development
The report also provides discussions of the key trends, as well as the regulatory, business, and clinical challenges facing the various sectors.
The report profiles key companies in the industry, including:
America’s Blood Centers
American Red Cross
Beijing Tiantan Biological Products, Ltd.
Bharat Serums and Vaccines Ltd.
Grifols Biologicals, Inc.
HUALAN BIOLOGICAL ENGINEERING
Lanzhou Institute of Biological Products Nordisk
Novo Nordisk A/S
ORTHO CLINICAL DIAGNOSTICS
Reliance Life Sciences
Shanghai RAAS Blood Products Co., Ltd.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Sinosource Biopharmaceutical, Inc.
Walvax Biotechnology Co., Ltd.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Animal Blood Plasma Products and Derivatives Market (Derivatives Type - Immunoglobulin, Fibrinogen, Serum Albumin, and Fetal Bovine Serum; Application - Cell Culture Media, Food Industry, Pharmaceutical ...
The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...
Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like ...